Evidence map›Paper›PMID 36756375›Full record

ArticleiScience2023

Distinct subsets of neutrophils crosstalk with cytokines and metabolites in patients with sepsis.

Upasana Parthasarathy, Yi Kuang, Gunjan Thakur, John D Hogan, Thomas P Wyche, James E Norton, Jason R Killough, Theodore R Sana, Caroline Beakes, BaoJen Shyong and 8 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Immature neutrophils are elevated in human PGD and linked to G-CSF-driven injury in a murine model of lung ischemia-reperfusion.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2026
    Article
  5. Article
  6. Article
  7. Multi‑omics reveal neutrophil heterogeneity in sepsis (Review).International journal of molecular medicine · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Upasana ParthasarathyDiscovery Immunology, Merck & Co.,Inc., Cambridge, MA, USA.
Yi KuangDiscovery Immunology, Merck & Co.,Inc., Cambridge, MA, USA.
Gunjan ThakurData and Genome Sciences, Merck & Co.,Inc., Cambridge, MA, USA.
John D HoganData and Genome Sciences, Merck & Co.,Inc., Cambridge, MA, USA.
Thomas P WycheMass Spectrometry & Biophysics, Merck & Co.,Inc., Cambridge, MA, USA.
James E NortonQuantitative Biosciences, Merck & Co.,Inc., West Point, PA, USA.
Jason R KilloughDiscovery Immunology, Merck & Co.,Inc., Cambridge, MA, USA.
Theodore R SanaMass Spectrometry & Biophysics, Merck & Co.,Inc., Cambridge, MA, USA.
Caroline BeakesPulmonary and Critical Care Division, Massachusetts General Hospital, Boston, MA, USA.
BaoJen ShyongPharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co.,Inc., West Point, PA, USA.
Rena N ZhangPharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co.,Inc., West Point, PA, USA.
Dario A GutierrezDiscovery Immunology, Merck & Co.,Inc., Cambridge, MA, USA.
Michael FilbinPulmonary and Critical Care Division, Massachusetts General Hospital, Boston, MA, USA.
David C ChristianiPulmonary and Critical Care Division, Massachusetts General Hospital, Boston, MA, USA.
Alex G TherienDiscovery Immunology, Merck & Co.,Inc., Cambridge, MA, USA.
Christopher H WoelkDiscovery Immunology, Merck & Co.,Inc., Cambridge, MA, USA.
Cory H WhiteData and Genome Sciences, Merck & Co.,Inc., Cambridge, MA, USA.
Roberta MartinelliDiscovery Immunology, Merck & Co.,Inc., Cambridge, MA, USA.
Merck & Co., Inc., Rahway, NJ, USA (United States) · USMassachusetts General Hospital · USQuantitative BioSciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is a life-threatening condition caused by a dysregulated host response to infection. Despite continued efforts to understand the pathophysiology of sepsis, no effective therapies are currently available. While singular components of the aberrant immune response have been investigated, comprehensive studies linking different data layers are lacking. Using an integrated systems immunology approach, we evaluated neutrophil phenotypes and concomitant changes in cytokines and metabolites in patients with sepsis. Our findings identify differentially expressed mature and immature neutrophil subsets in patients with sepsis. These subsets correlate with various proteins, metabolites, and lipids, including pentraxin-3, angiopoietin-2, and lysophosphatidylcholines, in patients with sepsis. These results enabled the construction of a statistical model based on weighted multi-omics linear regression analysis for sepsis biomarker identification. These findings could help inform early patient stratification and treatment options, and facilitate further mechanistic studies targeting the trifecta of surface marker expression, cytokines, and metabolites.

Indexed as

Cell biologyComponents of the immune systemImmunitySystems biology

Identifiers

PMID36756375
PMCPMC9900520
OpenAlexW4313703977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.